Lopez-Perez, Mary
Jain, Aarti
Davies, D. Huw
Vásquez-Jiménez, Juan M.
Herrera, Sonia M.
Oñate, José
Felgner, Philip L.
Herrera, Sócrates
Arévalo-Herrera, Myriam
Clinical trials referenced in this document:
Documents that mention this clinical trial
Profiling the antibody response of humans protected by immunization with Plasmodium vivax radiation-attenuated sporozoites
https://doi.org/10.1038/s41598-024-53175-0
Funding for this research was provided by:
National Heart, Lung and Blood Institute at the National Institutes of Health (5R01HL086488, SH)
Colombian National Research Council, COLCIENCIAS (527-2009, SH)
National Institute of Allergy and Infectious Diseases (AI089686)
International Centers of Excellence for Malaria Research (5U01AI155363-03)
Article History
Received: 28 October 2023
Accepted: 29 January 2024
First Online: 2 February 2024
Competing interests
: PLF and DHD have patent applications pertaining to this work and PLF owns stock in Antigen Discovery Inc. that has licensed the protein microarray technology described here. The other authors declare that they have no competing interests.